Literature DB >> 10390373

The impact of HIV infection on Mycobacterium kansasii disease in South African gold miners.

E L Corbett1, G J Churchyard, M Hay, P Herselman, T Clayton, B Williams, R Hayes, D Mulder, K M De Cock.   

Abstract

The impact of human immunodeficiency virus (HIV) infection on Mycobacterium kansasii disease in miners was investigated with a retrospective study covering a single workforce. M. kansasii, isolated from 43 HIV-positive and 202 HIV-negative miners, was the most common nontuberculous mycobacterial (NTM) species in both HIV groups. CD4 counts were unusually high for M. kansasii disease (mean 490 x 10(6)/L, from 14 HIV-positive men). Treatment outcomes were similar: mortality during treatment was higher in HIV-positive than in HIV-negative men (9% and 2%, respectively), but not significantly so. The majority of a sample of 31 HIV-positive and 92 HIV-negative men had radiological silicosis and/or old tuberculosis scarring prior to M. kansasii disease. A normal premorbid radiograph was more common in HIV-positive men (45% versus 24%; odds ratio [OR], 2.62; 95% confidence interval [95% CI], 1.01 to 6.67). New cavitation was less common (55% versus 78%; OR, 0.34; 95% CI, 0.13 to 0.88) and new hilar adenopathy more common (OR, 5.07; 95% CI, 1.24 to 21.9) in HIV-positive than in HIV-negative men. Miners, who have additional NTM risk factors, develop M. kansasii disease that occurs at an earlier stage of HIV infection and more closely resembles disease in HIV-negative men than has been found for HIV-associated M. kansasii disease in other settings.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10390373     DOI: 10.1164/ajrccm.160.1.9808052

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  12 in total

Review 1.  Nontuberculous mycobacteria and the lung: from suspicion to treatment.

Authors:  Emmet E McGrath; Zoe Blades; Josie McCabe; Hannah Jarry; Paul B Anderson
Journal:  Lung       Date:  2010-04-09       Impact factor: 2.584

2.  Rapid drug tolerance and dramatic sterilizing effect of moxifloxacin monotherapy in a novel hollow-fiber model of intracellular Mycobacterium kansasii disease.

Authors:  Shashikant Srivastava; Jotam Pasipanodya; Carleton M Sherman; Claudia Meek; Richard Leff; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

3.  Non-tuberculous Mycobacteria isolated from Pulmonary samples in sub-Saharan Africa - A Systematic Review and Meta Analyses.

Authors:  Catherine Okoi; Suzanne T B Anderson; Martin Antonio; Sarah N Mulwa; Florian Gehre; Ifedayo M O Adetifa
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

4.  Detection of phospholipase C in nontuberculous mycobacteria and its possible role in hemolytic activity.

Authors:  A Gomez; A Mve-Obiang; B Vray; W Rudnicka; I C Shamputa; F Portaels; W M Meyers; P A Fonteyne; L Realini
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

5.  Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome.

Authors:  D Shitrit; R Priess; N Peled; G Bishara; D Shlomi; M R Kramer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10       Impact factor: 3.267

6.  Species-Specific Risk Factors, Treatment Decisions, and Clinical Outcomes for Laboratory Isolates of Less Common Nontuberculous Mycobacteria in Washington State.

Authors:  Emily S Ford; David J Horne; Javeed A Shah; Carolyn K Wallis; Ferric C Fang; Thomas R Hawn
Journal:  Ann Am Thorac Soc       Date:  2017-07

7.  Bead array direct rRNA capture assay (rCapA) for amplification free speciation of Mycobacterium cultures.

Authors:  Hans de Ronde; Paula González Alonso; Dick van Soolingen; Paul R Klatser; Richard M Anthony
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

8.  Clinical Relevance of Nontuberculous Mycobacteria Isolated from Sputum in a Gold Mining Workforce in South Africa: An Observational, Clinical Study.

Authors:  Clare L van Halsema; Violet N Chihota; Nicolaas C Gey van Pittius; Katherine L Fielding; James J Lewis; Paul D van Helden; Gavin J Churchyard; Alison D Grant
Journal:  Biomed Res Int       Date:  2015-05-28       Impact factor: 3.411

9.  Predictors of developing Mycobacterium kansasii pulmonary disease within 1 year among patients with single isolation in multiple sputum samples: A retrospective, longitudinal, multicentre study.

Authors:  Hung-Ling Huang; Meng-Hsuan Cheng; Po-Liang Lu; Chia-Jung Liu; Inn-Wen Chong; Jann-Yuan Wang
Journal:  Sci Rep       Date:  2018-12-13       Impact factor: 4.379

Review 10.  Health risks of gold miners: a synoptic review.

Authors:  Ronald Eisler
Journal:  Environ Geochem Health       Date:  2003-09       Impact factor: 4.898

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.